When I find a new job I will be gone. - werkgeversreview Senior CTA bij Merck

2,0
26 jan 2009
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The people there are friendly and easy to work with. The benefits work well but tuition reimbursement is only 90 percent and nothing for books or fees. HR is very secretive so you don't have to worry about if you get paid enough for not. It is easy to play the political game and disregard the supposed corporate ideals. All this so you can find out that you don't get free coffee any more and the 4th lemon slice costs you a nickel. The water coolers no longer have hot water but it is easy to nuke the water since microwaves are right next to them.

Minpunten

The people all see through the spin of management that they care about you. Which is easy when they know people are underpaid and do nothing. The promotion scheme is very political and so are selections for extra activities like mentoring. The praise is usually behind closed doors and should you mess up everyone is very quick to blame. In fact they would rather spend time finding who is at fault instead of coming up with a solution and moving forward. The work I don't know are seen to mean that you are not very competent. Thank you for your time and support

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle